On ECHEMI
Home > Drugs > Uterine rupture
Uterine rupture
Uterine rupture refers to a laceration of the uterine body or lower uterine segment during delivery or pregnancy. It is a serious obstetric complication that threatens the lives of mothers and children. Deaths are mainly caused by hemorrhage and infectious shock. With the improvement of obstetric quality, the establishment and gradual improvement of urban and rural maternal and child health care networks, the incidence rate has dropped significantly. It is rarely seen in urban hospitals, but it occurs from time to time in remote rural areas. The vast majority of uterine ruptures occur after 28 weeks of pregnancy, most commonly during delivery. The current incidence rate is controlled below 1‰, the maternal mortality rate is 5%, and the infant mortality rate is as high as 50% to 75% or even higher.
  • Site of disease:

    Uterus
  • Infectious :

    Not contagious
  • Frequent population:

    Maternity
  • Related symptoms:

    Premonition of uterine rupture Lower abdominal pain Irritability Uterine tenderness Signs of uterine rupture
  • Concurrent disease:

Related Drugs
Carbazochrome Sodium Sulfonate
Indication: It is used for bleeding from urinary system, upper digestive tract, respiratory tract and gynecological diseases, and can also be used for bleeding from trauma and surgery.
Manufacturer:

Hainan Yishun Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.